A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity

NCT06737536 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: NNC0662-0419
OTHER: Placebo (NNC0662-0419)

Sponsor

Novo Nordisk A/S